Featured Article
Biography of Michael Cloutier, Past HCSC Chair

Michael Cloutier is the President and CEO of AstraZeneca Canada Inc., one of Canada's leading pharmaceutical companies. 

With over 23 years of pharmaceutical industry experience, Mr. Cloutier was appointed president and CEO of AstraZeneca Canada Inc. on October 1st, 2003. He recently served as president and CEO of the former Pharmacia Canada organization. Prior to the merger of Pharmacia & UpJohn with the Monsanto Company and its G.D. Searle unit, he was President of Searle Canada. He has also worked with the industry in Latin America.
He currently serves on the Executive Committee of the Board of Directors for Canada's Research Based Pharmaceutical Companies (Rx&D) as Treasurer and is also Chair of the Ontario Regional Committee. Mike also serves on a number of boards including the Canadian Stroke Network, the Canadian Pharmaceutical Distribution Network (CPDN), the ACT Foundation, the Toronto Downtown Jazz Festival and the Board of Governors of Joseph Brant Memorial Hospital. Mike is the chair of the University of Toronto at Mississauga Hazel McCallion Academic Learning Centre project and sits on the Humber College Curriculum Advisory Board. In November 2005, he was inducted into the Canadian Healthcare Marketing Hall of Fame.
AstraZeneca is one of the leading global pharmaceutical companies with a formidable product portfolio spanning six major therapeutic areas: gastrointestinal, cardiovascular, oncology, respiratory, neuroscience and infection.

Ranked as one of the top 50 employers in Canada by The Globe and Mail's Report on Business Magazine for the fourth consecutive year, AstraZeneca's Canadian headquarters and manufacturing facilities are located in Mississauga, Ontario, with a state-of-the-art basic pain research centre based in Montreal, Quebec.